J. Roujeau

Evolving pattern of drug-induced toxic epidermal necrolysis.

J. Roujeau, O. Chosidow, J. Revuz, 1993, Dermatology.

Poor relevance of a lymphocyte proliferation assay in lamotrigine‐induced Stevens–Johnson syndrome or toxic epidermal necrolysis

L. Naldi, J. Roujeau, M. Mockenhaupt, 2012, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Interventions for toxic epidermal necrolysis.

M. Mockenhaupt, J. Roujeau, A. Townshend, 2002, The Cochrane database of systematic reviews.

Characteristics of toxic epidermal necrolysis in patients undergoing long-term glucocorticoid therapy.

J. Roujeau, O. Chosidow, J. Revuz, 1995, Archives of dermatology.

Toxic epidermal necrolysis (Lyell syndrome).

J. Roujeau, J. Guillaume, J. Fabre, 1990, Journal of the American Academy of Dermatology.

Drug-induced toxic epidermal necrolysis.

J. Roujeau, P. Wolkenstein, J. Revuz, 1998, Clinics in dermatology.

Pulse glucocorticoid therapy. The 'big shot' revisited.

J. Roujeau, J. Roujeau, 1996, Archives of dermatology.

Hypothermia related to air-fluidized bed

J. Roujeau, J. Revuz, P. Wolkenstein, 2005, Intensive Care Medicine.

Reactions and interactions of some commonly used systemic drugs in dermatology.

J. Roujeau, H. Bocquet, L. L. Cleach, 1998, Dermatologic clinics.

MR imaging in acute infectious cellulitis.

A. Rahmouni, J. Roujeau, O. Chosidow, 1994, Radiology.

Drug-induced toxic epidermal necrolysis. II. Current aspects.

J. Roujeau, J. Roujeau, 1993, Clinics in dermatology.